Investment portfolio.
We provide smart capital for Belgian innovation and driving socio-economic growth.
Our role is to create
sustainable long-term value.
all our investments are driven by our values.
QBIC II FUND ARKIV
Détention du capital20.37 %
Investment Fund specializing in investing in spin-offs of research institutes associated with Gent Universiteit, Vrije Universiteit Brussel and Universiteit of Antwerpen. It will also seek cooperation with the Belgian hospitals.
Qbic III Fund
Détention du capital14.12 %
Qbic is an inter-university (UGent, UAntwerpen and VUBrussel) investment fund focusing on the transformation of technological breakthroughs into sustainable business
<div id="ConnectiveDocSignExtentionInstalled" data-extension-version="1.0.4"></div>
RAILWAY INFRASTRUCTURE FUND
Détention du capital100 %
Company that aims at selling the sites that used to belong to the railway infrastructure to real estate developers.
REGENERO
Détention du capital20.74 %
Established in February 2019, the Regenero impact fund provides unique access to companies that are helping to address today's social and environmental challenges and to advance the regenerative economy through their products and services.
RELAUNCH FOR THE FUTURE
Détention du capital100 %
Holding company activities.
Relaunch for the Future
Détention du capital100 %
Relaunch for the Future is a subsidiary of SFPIM that invests in short-term recovery needs. Investments in short-term recovery are made through regional recovery initiatives and through a federal fund of its own (Belgian Recovery Fund), which was set up to complement the regional initiatives, for federal government investments in companies affected by the coronavirus crisis.
REMYND
Détention du capital11.07 %
reMYND is a clinical-stage company developing treatments for Alzheimer's disease, diabetes and other diseases caused by cellular dysfunction, using its own drug discovery platform. reMYND stands out from the competition by seeking new mechanisms that address the underlying causes and regenerate the affected human cells, rather than simply treating the symptoms or slowing the disease.
Royal park investments
Détention du capital5.8 %
Special Purpose Vehicle with a view to managing and scaling down structured credit instruments (related to participation in Fortis Bank)
RX/SEAPORT
Détention du capital4.63 %
RX/SeaPort was established to prepare the port of the administrative changes due to the Brexit. The result is that the physical movement of goods is not interrupted by the modified administration and that the competitive position of the port Zeebruges is strengthened.
SABENA AEROSPACE ENGINEERING
Détention du capital0.00 %
Sabena Aerospace Engineering is a company active in airplanes repair and maintenance for airlines companies as well as for government operators / defense.
SAFRAN AERO BOOSTERS
Détention du capital1.78 %
The company mainly develops, manufactures and assembles products for aeronautical and space systems.
SCALE-UPS
Détention du capital48.98 %
Scale-ups.eu is an initiative aimed at accelerating the development of scale-ups in Europe by bringing them into contact with an extensive network of investors while at the same time promote and accelerate cooperation with high-tech and large companies in its network.
SCALEFUND II
Détention du capital19.41 %
Scalefund II is an investment fund dedicated to the post-seed and pre-scaleup phase, with an investment that can vary between EUR 300,000 and EUR 500,000 for an initial commitment, and the possibility of following it up later. The fund characteristically invests only in projects that have already raised one or more funds, and we know its existing investors.
SEEDER FUND
Détention du capital18.29 %
Seeder Fund has an innovative approach to better meet the need among Belgian start-ups for early-stage venture capital. This approach allows start-ups to save a lot of time in the first three years of their existence by being able to concentrate on their growth instead of on their short and medium-term financing.
SEQUANA MEDICAL
Détention du capital6.68 %
Sequana Medical has developed an innovative implantable pump, patented and approved in the EU for treatment of fluid accumulations in the abdominal cavity. The pump can be implanted in patients with severe liver disease and/ or cancer to regulate the moisture balance in the human body, which makes the patient’s quality of life bett
